Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1,4-Dibenzyl-[1,4]diazepane-6-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

377780-16-0

Post Buying Request

377780-16-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

377780-16-0 Usage

Chemical class

Organic compound

Subclass

Diazepanes

Type

Heterocyclic compound

Structure

Seven-membered diazepane ring

Substituents

Benzyl groups at the 1 and 4 positions

Functional group

Carboxylic acid group at the 6 position

Potential applications

Pharmaceutical (neurological disorders)

Mechanism of action

Modulation of neurotransmitter receptors

Additional use

Building block in chemical synthesis for other organic compounds

Check Digit Verification of cas no

The CAS Registry Mumber 377780-16-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,7,7,8 and 0 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 377780-16:
(8*3)+(7*7)+(6*7)+(5*7)+(4*8)+(3*0)+(2*1)+(1*6)=190
190 % 10 = 0
So 377780-16-0 is a valid CAS Registry Number.

377780-16-0Relevant articles and documents

Speeding up heterogeneous catalysis with an improved highly reusable catalyst for the preparation of enantioenriched secondary alcohols

Sánchez-Carnerero, Esther M.,Sandoval-Torrientes, Rafael,Urieta-Mora, Javier,Moreno, Florencio,Maroto, Beatriz L.,de la Moya, Santiago

, p. 23 - 30 (2017)

A new catalytic heterogeneous system, very efficient and highly reusable, for the preparation of enantioenriched secondary alcohols through the addition of diethylzinc to benzaldehyde has been developed. This system is based on a chiral bis(hydroxyamide) ligand supported on crosslinked polystyrene. The catalyst has been shown to be very efficient, leading to the corresponding secondary alcohol with an enantiomeric excess of 93% in a time as short as 2?h and using just 4% of the heterogeneous catalyst and just 1.5 equivalents of the organozinc reagent. We have demonstrated that the new catalyst is very stable and can be efficiently recycled with no decrease in yield or enantioselectivity. The presented system has an unquestionable interest for the potential transfer of the reaction to the industry by using catalytic fluidized-bed reactors.

A Carbon Electrode Functionalized by a Tricopper Cluster Complex: Overcoming Overpotential and Production of Hydrogen Peroxide in the Oxygen Reduction Reaction

Thiyagarajan, Natarajan,Janmanchi, Damodar,Tsai, Yi-Fang,Wanna, Wondemagegn Hailemichael,Ramu, Ravirala,Chan, Sunney I.,Zen, Jyh-Myng,Yu, Steve S.-F.

supporting information, p. 3612 - 3616 (2018/03/05)

A study of the oxygen reduction reaction (ORR) on a screen printed carbon electrode surface mediated by the tricopper cluster complex Cu3(7-N-Etppz(CH2OH)) dispersed on electrochemically reduced carbon black, where 7-N-Etppz(CH2OH) is the ligand 3,3′-(6-(hydroxymethyl)-1,4-diazepane-1,4-diyl)bis(1-(4-ethyl piperazin-1-yl)propan-2-ol), is described. Onset oxygen reduction potentials of about 0.92 V and about 0.77 V are observed at pH 13 and pH 7 vs. the reversible hydrogen electrode, which are comparable to the best values reported for any synthetic copper complex. Based on half-wave potentials (E1/2), the corresponding overpotentials are about 0.42 V and about 0.68 V, respectively. Kinetic studies indicate that the trinuclear copper catalyst can accomplish the 4 e? reduction of O2 efficiently and the ORR is accompanied by the production of only small amounts of H2O2. The involvement of the copper triad in the O2 activation process is also verified.

Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV

-

, (2008/06/13)

The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 377780-16-0